Log in to save to my catalogue

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1738980

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease

About this item

Full title

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease

Publisher

London: BMJ Publishing Group Ltd

Journal title

Journal of neurology, neurosurgery and psychiatry, 2004-03, Vol.75 (3), p.370-376

Language

English

Formats

Publication information

Publisher

London: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

Objectives: Declines in brain glucose metabolism have been described early in Alzheimer’s disease (AD), and there is evidence that a genetic predisposition to AD contributes to accelerate this process. The epsilon4 (e4) allele of the apolipoprotein E (ApoE) gene has been implicated as a major risk factor in this process. The aim of this FDG-PET stu...

Alternative Titles

Full title

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1738980

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1738980

Other Identifiers

ISSN

0022-3050

E-ISSN

1468-330X

DOI

10.1136/jnnp.2003.014993

How to access this item